poisar

Stocks · News reference

AGC Affirms FY2026 GAAP EPS Guidance of $0.46 vs $0.42 Est; Affirms FY2026 Sales Guidance of $14.027B

Aug 4, 2026, 8:06 AMBenzinga Newsdesk

AGC (OTC:ASGLY) affirms FY2026 GAAP EPS guidance from $0.46 to $0.46 vs $0.42 analyst estimate. Affirms FY2026 sales outlook from $14.027 billion to $14.027 billion.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ASGLY
Source
benzinga
Observed
Aug 4, 2026, 8:06 AM
Checked
Aug 4, 2026, 8:06 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 27, 2026, 10:56 AMResearchandmarkets.Com

    High Performance Fluoropolymers Market Forecast 2026-2032 | Semiconductor, Electric Vehicle and Battery Demand Accelerates High Performance Fluoropolymers Market Growth

    The global high-performance fluoropolymers market is projected to grow from USD 5.17 billion in 2026 to USD 7.82 billion by 2032 at a CAGR of 7.11%, driven by semiconductor fabrication, electric vehicle electrification, battery technology, and hydrogen infrastructure demands. Key growth factors include regulatory compliance requirements, AI-driven innovation in materials discovery, and expanding applications across aerospace, medical devices, and industrial coatings.

    Read original at globenewswire-inc
    CCARKAYASGLY
  3. Jul 28, 2026, 10:50 PMGlobe Newswire

    AGCバイオロジクス、横浜拠点における数億ドル (数百億円) 規模の商業製造契約を獲得

    AGC Biologics has secured a multi-year commercial contract worth hundreds of millions of dollars with a major international biopharmaceutical company, which will utilize half of the manufacturing capacity at its new Yokohama facility opening in 2027. The contract covers production of five biopharmaceutical programs with a minimum of 35 batches annually, reflecting growing demand for geopolitically stable biopharmaceutical supply chains.

    Read original at globenewswire-inc
    ASGLY